The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS ...
UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare ...
UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...
UnitedHealth Group is charging patients a markup for key ... The report, which levels the same allegations at CVS and Cigna, is the latest indictment of America’s broken healthcare system ...
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...